A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.
about
The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyVitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation.Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.DNA Repair in Despair-Vitamin D Is Not Fair.Vitamin D in prostate cancer.
P2860
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A phase I/II pharmacokinetic a ...... ed non-small-cell lung cancer.
@en
type
label
A phase I/II pharmacokinetic a ...... ed non-small-cell lung cancer.
@en
prefLabel
A phase I/II pharmacokinetic a ...... ed non-small-cell lung cancer.
@en
P2093
P2860
P1476
A phase I/II pharmacokinetic a ...... ed non-small-cell lung cancer.
@en
P2093
C S Johnson
D E Brenner
G P Kalemkerian
J R Muindi
P J Stella
P2860
P2888
P304
P356
10.1007/S00280-013-2109-X
P577
2013-02-23T00:00:00Z